Turing Pharmaceuticals
-
{
- All
- News
-
Turing Pharma Names Chairman To Replace Martin Shkreli As CEO
- Saturday December 19, 2015
- World News | Reuters
Martin Shkreli, the poster boy for prescription drug price increases who was arrested for securities fraud this week, has stepped down from his post as chief executive officer of Turing Pharmaceuticals Inc, the company said on Friday.
-
www.ndtv.com
-
Life-Saving Pill That Had Its Price Hiked To $750 Now Has A $1 Competitor
- Saturday October 24, 2015
- World News | Elahe Izadi, The Washington Post
Turing Pharmaceuticals chief executive Martin Shkreli found himself in the middle of a media firestorm last month as he adamantly defended his company's 4,000 percent drug price hike as "altruistic."
-
www.ndtv.com
-
CEO Who Raised Price Of Old Pill More Than $700 Calls Journalist A 'Moron' For Asking Why
- Tuesday September 22, 2015
- World News | Ariana Eunjung Cha, The Washington Post
John Carroll, the editor of Fierce Biotech, a daily newsletter about the industry, was one of the first to ask Turing chief executive Martin Shkreli directly to explain the move.
-
www.ndtv.com
-
Turing Pharma Names Chairman To Replace Martin Shkreli As CEO
- Saturday December 19, 2015
- World News | Reuters
Martin Shkreli, the poster boy for prescription drug price increases who was arrested for securities fraud this week, has stepped down from his post as chief executive officer of Turing Pharmaceuticals Inc, the company said on Friday.
-
www.ndtv.com
-
Life-Saving Pill That Had Its Price Hiked To $750 Now Has A $1 Competitor
- Saturday October 24, 2015
- World News | Elahe Izadi, The Washington Post
Turing Pharmaceuticals chief executive Martin Shkreli found himself in the middle of a media firestorm last month as he adamantly defended his company's 4,000 percent drug price hike as "altruistic."
-
www.ndtv.com
-
CEO Who Raised Price Of Old Pill More Than $700 Calls Journalist A 'Moron' For Asking Why
- Tuesday September 22, 2015
- World News | Ariana Eunjung Cha, The Washington Post
John Carroll, the editor of Fierce Biotech, a daily newsletter about the industry, was one of the first to ask Turing chief executive Martin Shkreli directly to explain the move.
-
www.ndtv.com